Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo

Epithelial ovarian carcinoma is the most lethal of gynecologic malignancies. There is a need to optimize the currently available treatment strategies and to urgently develop novel therapeutic agents against chemotherapy-resistant disease. The objective of our study was to evaluate neratinib’s precli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Med Oncol
Main Authors: Menderes, Gulden, Bonazzoli, Elena, Bellone, Stefania, Black, Jonathan D., Lopez, Salvatore, Pettinella, Francesca, Masserdotti, Alice, Zammataro, Luca, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Azodi, Masoud, Schwartz, Peter E., Santin, Alessandro D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5896014/
https://ncbi.nlm.nih.gov/pubmed/28397106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-017-0956-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados